...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >EGFL7 ligates αvβ3 integrin to enhance vessel formation.
【24h】

EGFL7 ligates αvβ3 integrin to enhance vessel formation.

机译:EGFL7连接αvβ3整联蛋白以增强血管形成。

获取原文
获取原文并翻译 | 示例

摘要

Angiogenesis, defined as blood vessel formation from a preexisting vasculature, is governed by multiple signal cascades including integrin receptors, in particular integrin αVβ3. Here we identify the endothelial cell (EC)-secreted factor epidermal growth factor-like protein 7 (EGFL7) as a novel specific ligand of integrin αVβ3, thus providing mechanistic insight into its proangiogenic actions in vitro and in vivo. Specifically, EGFL7 attaches to the extracellular matrix and by its interaction with integrin αVβ3 increases the motility of EC, which allows EC to move on a sticky underground during vessel remodeling. We provide evidence that the deregulation of EGFL7 in zebrafish embryos leads to a severe integrin-dependent malformation of the caudal venous plexus, pointing toward the significance of EGFL7 in vessel development. In biopsy specimens of patients with neurologic diseases, vascular EGFL7 expression rose with increasing EC proliferation. Further, EGFL7 became upregulated in vessels of the stroke penumbra using a mouse model of reversible middle cerebral artery occlusion. Our data suggest that EGFL7 expression depends on the remodeling state of the existing vasculature rather than on the phenotype of neurologic disease analyzed. In sum, our work sheds a novel light on the molecular mechanism EGFL7 engages to govern physiological and pathological angiogenesis.
机译:血管生成被定义为由先前存在的脉管系统形成的血管,由包括整联蛋白受体,特别是整联蛋白αVβ3的多个信号级联控制。在这里,我们确定内皮细胞(EC)分泌因子表皮生长因子样蛋白7(EGFL7)作为整合素αVβ3的新型特异性配体,从而提供了对其在体内和体外促血管生成作用的机制的认识。具体而言,EGFL7附着在细胞外基质上,并通过其与整联蛋白αVβ3的相互作用而增加了EC的运动性,从而使EC在血管重塑期间能够在粘性地下运动。我们提供的证据表明,斑马鱼胚胎中EGFL7的失控会导致尾静脉丛的严重整合素依赖性畸形,从而表明EGFL7在血管发育中的重要性。在神经系统疾病患者的活检标本中,随着EC增殖的增加,血管EGFL7表达上升。此外,使用可逆性大脑中动脉闭塞的小鼠模型,中风半影血管中的EGFL7上调。我们的数据表明,EGFL7表达取决于现有脉管系统的重塑状态,而不取决于所分析的神经系统疾病的表型。总之,我们的工作为EGFL7参与调控生理和病理性血管生成的分子机制提供了新的思路。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号